@article{ref1,
title="Post-COVID syndrome and suicide risk",
journal="QJM: Journal of the Association of Physicians of Great Britain and Ireland",
year="2021",
author="Sher, Leo",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="A significant number of COVID-19 patients continue to have symptoms related to COVID-19 after the acute phase of illness. This post-COVID condition is sometimes called &quot;post-COVID syndrome,&quot; &quot;long COVID,&quot; or &quot;post-acute COVID-19.&quot; Persistent psychiatric symptoms among COVID-19 survivors such as depression, anxiety, post-traumatic symptoms, and cognitive impairment may be related to psychological factors and neurobiological injury. COVID-19 related neurological symptoms including anosmia, ageusia, dizziness, headache and seizures may persist for a long time after the acute COVID-19 illness. Many COVID-19 survivors experience persistent physical symptoms such as cough, fatigue, dyspnea and pain after recovering from their initial illness. There is a high probability that symptoms of psychiatric, neurological and physical illnesses as well as inflammatory damage to the brain in individuals with post-COVID syndrome increase suicidal ideation and behavior in this patient population. COVID-19 survivors without post-COVID syndrome may also be at elevated suicide risk. Studies of suicidality in COVID-19 survivors are urgently needed and will be a new area of suicide research. An appropriate management of psychiatric, neurological and medical conditions may reduce suicide risk among COVID-19 survivors with or without post-COVID syndrome.<p /> <p>Language: en</p>",
language="en",
issn="1460-2725",
doi="10.1093/qjmed/hcab007",
url="http://dx.doi.org/10.1093/qjmed/hcab007"
}